Direktorat Registrasi ObatValid

INVEGA

BPOM Number: DKI2110901714B1
Approved: 7 June 2026
Expiry: 6 June 2031
Form: TABLET PELEPASAN LAMBAT

About This Registration

INVEGA is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2110901714B1. Its current registration status is Valid, with the licence valid until 6 June 2031. The product is registered to INTEGRATED HEALTHCARE INDONESIA - INDONESIA. BPOM first approved this registration in June 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 4 BLISTER @ 7 TABLET PELEPASAN LAMBAT
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

INTEGRATED HEALTHCARE INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
NPWP: 032304875063000
owner
View profile →

Manufacturing Sites

INTEGRATED HEALTHCARE INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
primary
View profile →

Ingredients (1)

PALIPERIDONE

Market Intelligence

Owner Portfolio: INTEGRATED HEALTHCARE INDONESIA - INDONESIA holds 64 BPOM registrations
Manufacturer Scale: INTEGRATED HEALTHCARE INDONESIA - INDONESIA produces 64 registered products
Registration Age: Registered for 3 months

FDA Cross-Reference

via openFDA

Generic Name: PALIPERIDONE PALMITATE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: INTRAMUSCULAR

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?